IAb-X11

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIAb-X11

Drug Alias NamePET imaging agent (ImaginAb/GlaxoSmithKline)

ClassificationDiagnostic agent (In vivo)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionPositron-emission tomography enhancers

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImaginab Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesImaginab Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A